Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

AN2 Therapeutics Adopts Limited Duration Stockholder Rights Plan, Which Is Scheduled To Expire On August 15, 2025

Author: Benzinga Newsdesk | August 16, 2024 07:04am

The Company recently became aware of the rapid accumulation of a significant amount (19.3%) of the common stock of the Company by BML Investment Partners, L.P. (BML), as disclosed in a Schedule 13G/A filing on August 14, 2024.

Subject to limited exceptions, if a person or group acquires 20% or more of the Company's common stock or announces a tender offer and the consummation of that offer would result in such ownership, each right will entitle its holder to purchase, at the right's then-current exercise price, a number of shares of common stock having a market value at that time of twice the right's exercise price. 

Posted In: ANTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist